Anwita Biosciences Inc.
PrivateLast Round
Series B
Jun 28, 2021
Est. Valuation
$50M
Total Funding Raised
$28.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Anwita Biosciences Inc. is a clinical-stage biotechnology company that develops next-generation cancer immunotherapies, including its lead candidate AWT020.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Anwita Biosciences Inc. Comparables
Compare Anwita Biosciences Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cugene Inc. | 83% | |
| Bright Peak Therapeutics | 81% | |
| Aulos Bioscience | 80% |
Anwita Biosciences Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 28, 2021 | ||||
| Series A | Jun 24, 2019 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors increased 65% MoM, reaching 2.8K.
- Mar 3, 2026
Monthly visitors increased 33% MoM.
Anwita Biosciences Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Anwita Biosciences Inc.'s valuation, stock price, and market status.
Is Anwita Biosciences Inc. a public or private company?
Anwita Biosciences Inc. is a private company.
What is the current stock price of Anwita Biosciences Inc.?
Anwita Biosciences Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Anwita Biosciences Inc. worth (valuation)?
Anwita Biosciences Inc.'s valuation is estimated at $50.0M based on funding round data.
Can I buy Anwita Biosciences Inc. stock?
Anwita Biosciences Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Anwita Biosciences Inc.'s last funding round?
Anwita Biosciences Inc.'s most recent funding round was Series B on June 24, 2019.
Who are the main investors in Anwita Biosciences Inc.?
Investor information for Anwita Biosciences Inc. is not publicly disclosed.
Will Anwita Biosciences Inc. IPO soon?
No public IPO plans have been announced for Anwita Biosciences Inc..
How can I track Anwita Biosciences Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Anwita Biosciences Inc.'s secondary market activity and sign up for updates.